NCT03788148

Bare Metal Stents and Drug Eluting Stents in Patients Who Underwent Blood Transfusion

Bare-metal Stents(BMS) Versus Drug-eluting Stents(DES) in Patients Who Underwent Periprocedural Blood Transfusion : A Nationwide Longitudinal Cohort Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 28,322 (actual)
• Sponsor: Samsung Medical Center · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Retrospective cohort study of Korean National Healthcare Insurance Database. To investigate clinical outcomes of bare metal stents versus drug eluting stents in patients who underwent periprocedural red blood cell transfusion.

Detailed description

A Korean nationwide, multi-center, retrospective observational cohort study. The receipt of red blood cell transfusion is at high risk of cardiac events or death. But little is know regarding the comparative outcomes of BMS and DES implantation in patients who underwent periprocedural red blood cell transfusion. Longitudinal data is collected from administrative claims in the national health insurance services of Korea. All Korean data(N=500,591) undergoing PCI from 2006 to 2015 is extracted. BMS or DES Patients(N=28,322) who received periprocedural red blood cell transfusion is investigate. Clinical outcomes until December 31, 2017 is investigate. Primary endpoint is a time to the first major adverse clinical event(MACE) defined as a composite of all-cause death, revascularization, critically ill cardiovascular status, or stroke.

Conditions

• Erythrocyte Transfusion
• Percutaneous Coronary Intervention
• Revascularization

Interventions

Type	Name	Description
DEVICE	Stent, red blood cell transfusion	BMS (Bare Metal Stent) and DES (drug-eluting stent) transplants with periprocedural red blood cell transfusion

Timeline

• Start date: 2018-01-03
• Primary completion: 2018-11-30
• Completion: 2018-11-30
• First posted: 2018-12-27
• Last updated: 2018-12-27

Locations

1 site across 1 country: South Korea